Biogen Snaps Up Apellis Pharma For $5.6 Billion, But Biogen Dives As Apellis Soars.
Share this article
Corporate
Score 56
Neutral
Biogen Snaps Up Apellis Pharma For $5.6 Billion, But Biogen Dives As Apellis Soars
Mar 31, 2026 13:02 UTC
BIIB, APLS, XBI, IBB
Immediate term
Stay Ahead of the Markets
Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.